Correction: Kao et al. RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655.

The authors would like to make corrections to a recently published paper [...].

The authors would like to make corrections to a recently published paper [1]. The reason for the correction is that Figure 5 was misplaced with all TNBC data, not TNBC LN (+) data. In addition, typo errors and citation errors were shown in Sections 3.1 and 3.2, and Reference No. 6.

Original Figure 5:

We would like it to be corrected as shown below.

New Figure 5:

The result of Section 3.1. Clinicopathological Characteristics and Progression of Breast Cancer.

A total of 264 LN+ patients, with a median age of 56 years.

The result of Section 3.2. A Significant Correlation Among RNF8, SNAI1, and CDH1 mRNA Expression in Patients with Breast Cancer.

SNAI1 showed a significant positive correlation (r value = 0.185).

The right reference No. 6 is: Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009, 119, 1420–1428. http://doi.org/10.1172/jci39104.

These changes do not change the results or conclusions of our paper. The authors would like to apologize to readers of JPM for this error. The published version will be updated on the article webpage, with a reference to this correction notice.